painreform.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi PRFX
PainReform Ltd. (PRFX) management is focusing on refining formulas while currently generating no sales. The EBITDA figure as of today illustrates the results of this strategy, where the 0.00 level reflects the status of the parameter. The innovative drug PRF-110 reduces the need for opioids by providing a three-day effect. However, geopolitical instability and sanctions on raw materials create risks for supply chains and patent protection.
Ringkesan rincian data analitis PainReform (PRFX)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi PainReform Ltd.|PRFX - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas PainReform Ltd|PRFX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku PainReform|PRFX - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak PainReform|Rasio likuiditas darurat painreform.com
- statistik bathi lan rasio pasar:
PRFX - Bathi resik perusahaan|Penghasilan resik sing dikarepake PainReform Ltd.|PRFX - Pangali P/E|Rasio prakiraan rega marang bathi painreform.com|PRFX - Pangali PEG|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan PainReform|PRFX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan PainReform|PRFX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan painreform.com|PRFX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep PainReform Ltd.
Ringkesan analitik perusahaan:PRFX (PainReform Corp)
PainReform Ltd. (PRFX) is developing long-acting analgesics for hospitals aimed at replacing opioids, which defines the potential for revenue scaling. An analysis of absolute operating profit allows for an assessment of the actual cash flow from these activities without the influence of debt load, while the absolute operating profit trend on this chart serves as an indicator of production asset efficiency across different cycle phases.
Karo sapa PainReform Ltd. saingan
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharmaceuticals Incorporated - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Perrigo Corp PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech (ALVO)|LQDA (liquidia.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Galapagos GLPG|ANIP (ANI Pharmaceuticals Inc) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|MannKind Corp. - Bathi operasional EBITDA|AMPH - Bathi operasional EBITDA|PCRX: Bathi operasional EBITDA|SPRY - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Theravance Biopharma, Inc.|Bathi operasional sadurunge amortisasi AQST (Aquestive Therapeutics Inc)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TNXP (Tonix Pharmaceuticals)|SXT Pharmaceuticals (SXTC) - Bathi sadurunge bunga, pajak, lan amortisasi|Eupraxia Pharma - Bathi operasional EBITDA|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi BHST|Invizyne Technologies, Inc. (EXOZ) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Oramed Pharmaceuticals Inc. (ORMP)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Entera Bio Ltd|HYFT: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ABVC BioPharma, Inc. (ABVC)|Bathi operasional sadurunge ngurangi amortisasi Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi FGEN|TELO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RANI: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SNYR (synergychc.com) - Bathi operasional sadurunge ngurangi amortisasi|RLYB: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|LEXX (Lexaria Bioscience Corp) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi PULM (Pulmatrix Corporation)|Bathi operasional sadurunge ngurangi amortisasi PTHL (Pheton Holdings Ltd)|Pendapatan operasional sadurunge ngurangi amortisasi aptorumgroup.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lyra Therapeutics LYRA|IBO (Impact BioMedical, Inc.) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|TNFA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi YCBD (cbdMD, Inc.)|CYTO: Bathi operasional EBITDA|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi LIPO (lipella.com)|Bathi operasional sadurunge ngurangi amortisasi OPTN|Bathi operasional sadurunge amortisasi PIRS (Pieris Pharmaceuticals Inc)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group SA (PROC)|PTPI: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA QLI (Qilian International)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SLRN|TFF Pharmaceuticals, Inc. - Bathi operasional EBITDA
